Abstract
Objective: To carry out a bibliographical survey on the consequences of COVID-19 on pregnant women. Bibliographic review: Complications resulting from COVID-19 infection during pregnancy include premature birth, rupture of membranes, fetal growth restriction, pre-eclampsia, low birth weight, fetal distress, need for cesarean section, conditions like pre-eclampsia and to HELLP syndrome, postpartum hemorrhage, maternal pneumonia, feeding intolerance, fetal asphyxia, and stillbirths. Pneumonia, when combined with COVID-19, increases in severity, requiring more aggressive interventions such as intubation and mechanical ventilation. Therefore, it is crucial to consider mothers and babies as risk groups, not only to prevent the disease, but also to study this population in detail. Final considerations: Early identification of possible complications, adequate management of symptoms and promotion of preventive measures are essential to minimize the negative impacts of SARS-CoV-2 infection during pregnancy. An individualized approach is essential for pregnant women with COVID-19. Education about the risks of diseases and medical monitoring are essential, and more research is needed to guide prevention and treatment strategies.
References
AGÊNCIA NACIONAL DE VIGILÂNCIA SANITÁRIA. Vacinas contra a COVID-19. Brasília: ANVISA, 2023.
ALBUQUERQUE LP, et al. Implicações da COVID-19 para pacientes gestantes. Revista Eletrônica Acervo Saúde, 2020; 12(10): 4632.
AMORIM MMR, et al. COVID-19 e Gravidez. Revista Brasileira de Saúde Materno Infantil, 2021; 21: 337-353.
ARINKAN SA, et al. Perinatal outcomes of pregnant women having SARS-CoV-2 infection. Taiwanese Journal of Obstetrics and Gynecology, 2021; 60(6): 1043-1046.
AVELAR FG de, et al. Complicações da COVID-19: desdobramentos para o Sistema Único de Saúde. Physis: Revista de Saúde Coletiva, 2021; 31.
BASCH CH, et al. Preventive behaviors conveyed on YouTube to mitigate transmission of COVID-19: cross-sectional study. JMIR public health and surveillance, 2020; 6(2): 1880.
BERGANTINI LS, et al. Factors associated with hospitalizations and deaths of pregnant women from Paraná due to COVID-19: a cross-sectional study. Revista Brasileira de Epidemiologia, 2024; 27: 240005.
BRASIL. Ministério da Saúde. Nota técnica nº 651/2021-CGPNI/DEIDT/SVS/MS. Brasília/DF. 2021a. Disponível em: https ://www.gov.br/saude/pt-br/assuntos/coronavirus/notas-tecnicas/2021/nota-tecnica- no-651-2021-cgpni-deidt-svs-ms.pdf/view. Acessado em: 10 de fevereiro de 2024.
BRASIL. Ministério da Saúde. Secretaria de Atenção Primária à Saúde. Departamento de Ações Programáticas e Estratégicas. Manual de Recomendações para a Assistência à Gestante e Puérpera Frente à Pandemia de Covid-19. Brasília-DF. 2021; 2: 84. Disponível em: https ://bvsms.saude.gov.br/bvs/publicacoes/manual_assistencia_gestante_puerpera_covid-19_2ed.pdf. Acessado: 26 de março de 2024.
BRASIL. Secretaria Extraordinária de Enfrentamento à COVID-19. Nota Técnica nº 2/2021- SECovid/GAB/SECovid/MS. Brasília; 2021b. Centros de Controle e Prevenção de Doenças. Disponível em:https ://www.gov.br/saude/pt-br/assuntos/coronavirus/notas-tecnicas/2021/nt-02-2021-secovid- vacinacao-gestantes-e-puerperas-1.pdf/view. Acessado em: 10 de janeiro de 2024.
COSTA FF, et al. Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020; 14: 809814.
DA ROCHA NOGUEIRA JM. Diagnóstico laboratorial da COVID-19 no Brasil. RBAC, 2020; 52(2): 117-21.
DE BARROS SC, et al. Efeitos da COVID-19 em gestantes: evidências no período pandêmico. Revista Eletrônica Acervo Saúde, 2023; 23(9): 13998.
DE BRITO RdeA, et al. Complicações gestacionais associadas a COVID-19. Research, Society and Development, 2022; 11(1): 56711125046.
DE SOUZA TA, et al. Vulnerabilidade e fatores de risco associados para COVID-19 em idosos institucionalizados. Revista Eletrônica Acervo Saúde, 2021; 13(2): 5947.
DOS REIS AGF e RIBEIRO KdaSC. Desfechos da gestação frente à contaminação por COVID-19: uma revisão sistemática. Health Residencies Journal-HRJ, 2022; 3(15): 414-430.
ESTEVÃO A. COVID-19. Acta Radiológica Portuguesa, 2020; 32(1): 5-6.
FALAVIGNA M, et al. Diretrizes para o tratamento farmacológico da COVID-19. Consenso da Associação de Medicina Intensiva Brasileira, da Sociedade Brasileira de Infectologia e da Sociedade Brasileira de Pneumologia e Tisiologia. Revista Brasileira de Terapia Intensiva, 2020; 32: 166-196.
GIDLÖF S, et al. COVID-19 in pregnancy with comorbidities: More liberal testing strategy is needed. Acta Obstet Gynecol Scand, 2020; 948-949.
GODOI APN, et al. Síndrome Respiratória Aguda Grave em gestantes e puérperas portadoras da COVID- Revista Brasileira de Saúde Materno Infantil, 2021; 21: 461-469.
HAROUN RA, et al. Interferon-y-induced protein 10 (IP-10) and sérum amyloid A (SAA) are excelente biomarkers for the prediction of COVID-19 progression and severity. Life Sci. 2021; 269: 119019.
INT J MOL SCI, 2021; 22(2): 974.
MAYO CLINIC PROCEEDINGS, 2020; 1750-1765.
MENDOZA M, et al. Pre‐eclampsia‐like syndrome induced by severe COVID‐19: a prospective observational study. BJOG: An International Journal of Obstetrics & Gynaecology, 2020; 127(11): 1374-1380.
NAIDU SAG, et al. COVID-19 durante a gravidez e pós-parto: I) Patobiologia da síndrome respiratória aguda grave coronavírus-2 (SARS-CoV-2) na interface materno-fetal. Revista de suplementos dietéticos, 2022; 19(1): 115-142.
NARANG K, et al. SARS-CoV-2 infection and COVID-19 during pregnancy: a multidisciplinary review.
OLIVEIRA C, et al. Protocolo COVID-19 a ser utilizada na Atenção Primária à Saúde. Technical Report, 2020.
PAULO GP, et al. COVID-19 e gestação. Revista Brasília Médica, 2021; 58: 1-6.
PHOSWA WN e KHALIQ OP. Is pregnancy a risk factor of COVID-19? European Journal of Obstetrics & Gynecology and Reproductive Biology, 2020; 252: 605-609.
POON LC, et al. Orientação provisória global sobre a doença de coronavírus 2019 (COVID-19) durante a gravidez e puerpério da FIGO e parceiros aliados: informações para profissionais de saúde. Revista Internacional de Ginecologia e Obstetrícia, 2020; 149(3): 273-286.
QIAO J. What are the risks of COVID-19 infection in pregnant women? The Lancet, 2020; 395(10226): 760-762.
ROSA JA, et al. Incidência do parto prematuro em gestantes com COVID. Brazilian Journal of Health Review, 2023, 3: 11110-11123.
ROYAL COLLEGE OF OBSTETRICIANS & GYNAECOLOGISTS et al. Royal College of Midwives. Coronavirus (COVID-19) infection in pregnancy. Information for healthcare professionals, 2020; 13.
SILVA LT, et al. Gestação e pandemia da COVID-19: Impactos no binômio materno-fetal. Research, Society and Development, 2021; 10(7): 23510716416.
WANG C-L, et al. Impact of COVID-19 on Pregnancy. International journal of medical sciences, 2021; 18(3): 763.
WEI SQ, et al. O impacto do COVID-19 nos resultados da gravidez: uma revisão sistemática e meta- análise. CMAJ, 2021; 193(16): E540-E548.
WHO. WORLD HEALTH ORGANIZATION et al. Coronavirus Disease (COVID-19) Dashboard: World Health Organization; 2020. Disponível em: https ://www.who.int/emergencies/diseases/novel-coronavirus- 2019. Acessado em: 25 de novembro de 2023.
YANG F, et al. Analysis of 92 deceased patients with COVID‐19. Journal of medical virology, 2020; 92(11): 2511-2515.
YUKI K, et al. COVID-19 pathophysiology: A review. Clinical immunology, 2020; 215: 108427.
ZARRILLI G, et al. The Immunopathological and Histological Landscape of COVID-19-Mediated lung Injury.
ZHENG M, et al. Esgotamento funcional de linfócitos antivirais em pacientes com COVID-19. Imunologia celular e molecular, 2020; 17(5): 533-535.
